Healthcare Utilization and Costs in Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma

被引：0

作者：

Denlinger, Nathan ^{[1
]}

Huang, Ying ^{[1
]}

Braunstein, Zachary ^{[1
]}

Sigmund, Audrey ^{[1
]}

Bajwa, Amneet ^{[1
]}

Kapoor, Nilesh ^{[2
]}

Agyeman, Akwasi ^{[1
]}

Fisher, Scott ^{[1
]}

Purdin, Zebulun ^{[3
]}

Neal, Alison ^{[1
]}

Yucebay, Filiz ^{[1
]}

Roddy, Julianna ^{[1
]}

Brammer, Jonathan ^{[1
]}

William, Basem ^{[3
]}

Saad, Ayman ^{[1
]}

Penza, Sam ^{[1
]}

Voorhees, Timothy ^{[1
]}

Kittai, Adam ^{[1
]}

de Lima, Marcos ^{[1
]}

Vasu, Sumithira ^{[1
]}

Jaglowski, Samantha ^{[1
]}

机构：

[1] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

[2] Ohio State Univ, Sch Med, Columbus, OH 43210 USA

[3] Ohio Hlth Blood & Bone Marrow Transplant Program, Columbus, OH USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷

关键词：

ABCL; CAR T; lymphoma; cost; toxicity; insurance;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ABCL-509

引用

页码：S381 / S382

页数：2

共 50 条

[1] Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma
Hamilton, Mark P.
Miklos, David B.
[J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (06) : 1053 - 1075
[2] Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma
Zhou, Wenyujing
Chen, Weihong
Wan, Xiaochun
Luo, Changru
Du, Xin
Li, Xiaoqing
Chen, Qian
Gao, Ruiwen
Zhang, Xiaohan
Xie, Mei
Wang, Mingjun
[J]. FRONTIERS IN GENETICS, 2022, 12
[3] Chimeric Antigen Receptor T-Cell Therapy and Imaging Applications for Large B-Cell Lymphoma
Mulholland, Nicola
Chandra, Julie
Sanderson, Robin
Kuhnl, Andrea
[J]. RADIOLOGY, 2023, 307 (05)
[4] Hospital healthcare resource utilization and costs for chimeric antigen T-cell therapy and autologous hematopoietic cell transplant in patients with large B-cell lymphoma in the United States
Cui, Chendi
Feng, Chaoling
Rosenthal, Ning
Wade, Sally W.
Curry, Laura
Fu, Christine
Shah, Gunjan L.
[J]. LEUKEMIA & LYMPHOMA, 2024, 65 (07) : 922 - 931
[5] Hospital healthcare resource utilization and costs for chimeric antigen T-cell therapy and autologous hematopoietic cell transplant in patients with large B-cell lymphoma in the United States
Cui, Chendi
Feng, Chaoling
Rosenthal, Ning
Wade, Sally W.
Curry, Laura
Fu, Christine
Shah, Gunjan L.
[J]. LEUKEMIA & LYMPHOMA, 2024,
[6] Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
Yin, Zixun
Zhang, Ya
Wang, Xin
[J]. BIOMARKER RESEARCH, 2021, 9 (01)
[7] Cytomegalovirus impact in b-cell lymphoma patients treated with chimeric antigen receptor t-cell therapy
Marquez-Algaba, E.
Pernas, B.
Esperalba, J.
Los-Arcos, I.
Carpio, C.
Iacoboni, G.
Barba, P.
Ruiz-Camps, I.
[J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 134 - 134
[8] Bilateral Cytomegalovirus Retinitis After Chimeric Antigen Receptor T-cell Therapy for B-cell Lymphoma
Meller, Leo
Jagadeesh, Vasan
Wilson, Katherine
Oca, Michael C.
Sestak, Timothy
Scott, Nathan
[J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
[9] Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
Zixun Yin
Ya Zhang
Xin Wang
[J]. Biomarker Research, 9
[10] Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas
Hu, Bei
Korsos, Victoria
Palomba, M. Lia
[J]. FRONTIERS IN ONCOLOGY, 2024, 14

← 1 2 3 4 5 →